Back
18 December 2024

Growth Factor: Rebranding for an Investment Portfolio Company

Written by Bracken

The Scenario

A mid-size PE firm had just acquired a life science company and needed to redefine its marketing strategy and brand presence pending another large-scale acquisition. With the goal of seamlessly merging identities while maintaining their distinct offering, the company’s leadership and investment partners realized they needed more than a generalized agency could offer. They needed domain expertise from a life sciences-specific partner to craft the right brand and messaging. 

Read on to see how we achieved nearly 300% digital traffic increase...

 
RECENT CASE STUDIES

The Data Most Companies Throw Away: How a Reconstruction Workflow Can Help Save a Clinical Trial

The Scenario Most sites discard the richest data a PET scanner produces; list mode data is usually..

Embedding Patient Engagement into Clinical Development

The Scenario A global, mid-sized biopharmaceutical company had made PFDD a strategic priority and..